Acadia Receives FDA Approval Of Nuplazid To Treat Parkinson's Disease Psychosis By: TalkMarkets April 29, 2016 at 21:29 PM EDT The company plans to begin selling the drug on June 1. Read More >> Related Stocks: Acadia Pharmaceutica